Literature DB >> 8609224

Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils.

Z M Dong1, J W Murphy.   

Abstract

High titers of cryptococcal polysaccharides in the serum and spinal fluid and the lack of cellular infiltrates in the infected tissues are hallmarks of disseminated cryptococcosis. Cryptococcal polysaccharides given intravenously to mice inhibit the influx of leukocytes into sites injected with inflammatory mediators. The purpose of this investigation was to determine if cryptococcal polysaccharides, i.e., glucuronoxylomannan (GXM), galactoxylomannan, and mannoprotein, affect expression of molecules on the surface of neutrophils that are important in extravasation. GXM in the absence of serum was shown to induce human neurophils to shed L-selectin, a molecule needed in the first step of neutrophil movement into tissues. In the presence of serum, GXM caused a further shedding of L-selectin. Shedding of L-selectin was evident by reduced amounts of L-selectin on the neutrophils treated with GXM and by increased levels of soluble L-selectin in the GXM-treated neutrophil supernatants. GXM also stimulated neutrophils to have reduced expression of TNF receptor. In contrast, GXM-treated neutrophils showed increased levels of CD15 and CD11b, and unchanged CD16 expression. In the absence of serum, galactoxylomannan and mannoprotein did not affect L-selectin, TNF receptor, CD15, CD11b, or CD16 on neutrophils but did induce loss of L-selectin in the presence of serum. Our results indicate that cryptococcal polysaccharides, especially GXM, can cause shedding of L-selectin from the surface of neutrophils, and this may prevent neutrophils from attaching to the endothelial cell surfaces. Blockage of this early step in cell migration from the vessels into tissues may be responsible in part for reduced cellular infiltration into infected tissues of individuals with disseminated cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609224      PMCID: PMC507105          DOI: 10.1172/JCI118466

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Authors:  T A Springer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

2.  The PI-linked receptor FcRIII is released on stimulation of neutrophils.

Authors:  T W Huizinga; C E van der Schoot; C Jost; R Klaassen; M Kleijer; A E von dem Borne; D Roos; P A Tetteroo
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

3.  Histologic response to capsule-deficient Cryptococcus neoformans.

Authors:  S G Farmer; R A Komorowski
Journal:  Arch Pathol       Date:  1973-12

4.  Cryptococcal infections in patients with acquired immune deficiency syndrome.

Authors:  R H Eng; E Bishburg; S M Smith; R Kapila
Journal:  Am J Med       Date:  1986-07       Impact factor: 4.965

5.  Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.

Authors:  E Reiss; R Cherniak; R Eby; L Kaufman
Journal:  Diagn Immunol       Date:  1984

6.  Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

Authors:  M R Shalaby; M A Palladino; S E Hirabayashi; T E Eessalu; G D Lewis; H M Shepard; B B Aggarwal
Journal:  J Leukoc Biol       Date:  1987-03       Impact factor: 4.962

7.  The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.

Authors:  T R Kozel; E C Gotschlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.

Authors:  J W Murphy; J W Moorhead
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.

Authors:  J W Murphy; R L Mosley; R Cherniak; G H Reyes; T R Kozel; E Reiss
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

View more
  36 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

3.  Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.

Authors:  R Blackstock; J W Murphy
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages.

Authors:  Zong Liang Chang; Dale Netski; Peter Thorkildson; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan.

Authors:  Z M Dong; L Jackson; J W Murphy
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans.

Authors:  S M Levitz; E A North; Y Jiang; S H Nong; H Kornfeld; T S Harrison
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.

Authors:  Robert A Larsen; Peter G Pappas; John Perfect; Judith A Aberg; Arturo Casadevall; Gretchen A Cloud; Robert James; Scott Filler; William E Dismukes
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors.

Authors:  R Blackstock; K L Buchanan; R Cherniak; T G Mitchell; B Wong; A Bartiss; L Jackson; J W Murphy
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

9.  Different proteolytic mechanisms involved in Fc gamma RIIIb shedding from human neutrophils.

Authors:  P J Middelhoven; J D Van Buul; P L Hordijk; D Roos
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

10.  Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.

Authors:  A Vecchiarelli; C Retini; A Casadevall; C Monari; D Pietrella; T R Kozel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.